Actively Recruiting

Age: 18Years - 70Years
All Genders
NCT03248284

Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons

Led by Odense University Hospital · Updated on 2025-12-05

30

Participants Needed

2

Research Sites

501 weeks

Total Duration

On this page

Sponsors

O

Odense University Hospital

Lead Sponsor

U

University of Southern Denmark

Collaborating Sponsor

AI-Summary

What this Trial Is About

Tendon pathologies (enthesitis) are a characteristic component of psoriatic arthritis (PsA), and are observed in 35% to 50% of PsA patients. The Achilles tendon is one of the most commonly affected sites. This condition often causes great morbidity and loss of quality of life, and response only suboptimal to current intervention strategies. One of the main obstacles for the development of effective treatment methods is that the disease mechanisms remain poorly understood. To our knowledge, no one has yet ascertained the presence and function of immune-competent cells and inflammatory markers in tendons tissue from PsA patients suffering from Achilles enthesitis.

CONDITIONS

Official Title

Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Fulfilling the CASPAR criteria for psoriatic arthritis
  • Insertional Achilles tendon pain
  • Ultrasound evidence of inflammatory disease at the painful Achilles tendon insertion, defined as abnormally hypoechoic or thickened tendon at the bony attachment seen in two planes, possibly with Doppler signal or bony changes including enthesophytes and erosions
Not Eligible

You will not qualify if you...

  • Having other inflammatory rheumatic diseases besides psoriatic arthritis
  • Ultrasound signs of complete rupture of the Achilles tendon
  • Not wishing to participate or not suitable for project evaluation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Odense University Hospital

Odense, Denmark, 5000

Actively Recruiting

2

Diagnostic Center

Silkeborg, Denmark

Actively Recruiting

Loading map...

Research Team

M

Maja S. Kragsnaes, MD PhDfellow

CONTACT

T

Torkell J. Ellingsen, Prof MD PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here